On Wednesday, Shares of Glu Mobile Inc. (NASDAQ:GLUU), lost -20.63% to $4.50.
Glu Mobile declared planned participation in the following forthcoming conferences:
- Chief Operating Officer and Chief Financial Officer, Eric R. Ludwig, is planned to present at the Oppenheimer 18th Annual Technology, Internet & Communications Conference in Boston, Mass. on Tuesday, August 11, 2015 at 4:25 p.m. Eastern time (1:25 p.m. Pacific time).
- Chief Operating Officer and Chief Financial Officer, Eric R. Ludwig, is planned to present at the Canaccord Genuity 35th Annual Growth Conference in Boston, Mass. on Wednesday, August 12, 2015 at 3:30 p.m. Eastern time (12:30 p.m. Pacific time).
Glu Mobile Inc. develops, publishes, and markets a portfolio of games for the smartphones and tablet devices users. The company offers free-to-play action, casual, racing, and sports genre mobile games.
Shares of E I Du Pont De Nemours And Co (NYSE:DD), declined -0.13% to $54.57, during its last trading session.
E I Du Pont De Nemours And Co, officially opened its Integrated Seed Science Center in Johnston, Iowa. This is the second facility in the DuPont Integrated Seed Science Network that is dedicated to developing and testing seed treatment formulations, applications and seed handling techniques. The Johnston center features experts and equipment that assist DuPont deliver the right seed treatments for growers’ fields to optimize genetic performance of seeds.
“The Johnston Integrated Seed Science Center ultimately assists us make our seed treatment products perform better for growers,” said Jeff Daniels, technical agronomy and application lead of the DuPont Seed Treatment Enterprise. “The facility gives us on-the-ground capabilities to match treatments with genetics for the best integrated seed solution for our customers.”
E I. du Pont de Nemours and Company operates as a science and technology based company worldwide. The company’s Agriculture segment offers corn hybrid, soybean, canola, sunflower, sorghum, inoculants, seed products, wheat, rice, herbicides, fungicides, and insecticides.
Finally, VCA Inc (NASDAQ:WOOF), ended its last trade with 0.34% gain, and closed at $58.35.
VCA stated financial results for the second quarter ended June 30, 2015, as follows: revenue raised 12.1% to a second quarter record of $548.8 million; gross profit raised 17.0% to $140.8 million; operating income raised 21.6% to $97.2 million; net income raised 19.1% to $54.3 million and diluted earnings per common share raised 27.5% to $0.65. Non-GAAP diluted earnings per common share, which excludes acquisition-related amortization, raised 27.3% to $0.70.
We also stated our financial results for the six months ended June 30, 2015, as follows: revenue raised 11.6% to $1.0 billion, gross profit raised 14.8% to $254.7 million, operating income raised 17.8% to $166.3 million, net income raised 16.3% to $92.6 million, and diluted earnings per common share raised 24.7% to $1.11. Our financial results for the six months ended June 30, 2015, on a Non-GAAP basis, are as follows: gross profit raised 14.6% to $266.0 million, operating income raised 17.3% to $178.0 million, net income raised 15.8% to $99.5 million, and Non-GAAP diluted earnings per common share raised 25.0% to $1.20.
VCA Inc. operates as an animal healthcare company in the United States and Canada. It operates through two segments, Animal Hospital and Laboratory. The Animal Hospital segment offers general medical and surgical services, in addition to specialized treatments comprising advanced diagnostic services, internal medicine, oncology, neurology, endocrinology, ophthalmology, dermatology, and cardiology for companion animals; and sells related retail and pharmaceutical products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
